NFKB1 and inflammatory bowel disease: For example, ginsenosides exhibit anti-inflammatory potential in treating inflammatory bowel disease (IBD) by suppressing the Mitogen-activated protein kinase (MAPK)/Nuclear factor kappa-B (NF-κB) pathway (Ahn et al., 2016).